Bone Biologics BBLGW
NASDAQ BBLGW
$8.24 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bone Biologics Corp (BBLGW) Assets (2012 - 2025)

Bone Biologics (BBLGW) posted quarterly Assets of $5.8 million for Q4 2025, up 50.11% year-over-year from $3.9 million in Q4 2024, and down 8.73% quarter-over-quarter from $6.4 million in Q3 2025.

Bone Biologics Corp (BBLGW) Assets (2012 - 2025) Analysis & Trends

Bone Biologics (BBLGW) has reported Assets for 14 consecutive years, with $5.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Assets rose 50.11% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (up 50.11% YoY), while the FY2025 annual figure was $5.8 million, up 50.11% from the prior year.
  • Assets eased to $5.8 million in Q4 2025 per BBLGW's latest filing, from $6.4 million in the prior quarter.
  • Across five years, Assets topped out at $8.5 million in Q4 2022 and bottomed at $4438.0 in Q2 2021.
  • Historically, Assets has averaged $4.6 million across 5 years, with a median of $5.1 million in 2022.
  • Annual changes were most pronounced in 2022 — Assets jumped 127409.71% — and 2024, when it plunged 58.11%.
  • Bone Biologics' Assets stood at $6.7 million in 2021, then advanced by 27.26% to $8.5 million in 2022, then tumbled by 56.0% to $3.7 million in 2023, then gained by 3.31% to $3.9 million in 2024, then jumped by 50.11% to $5.8 million in 2025.
  • Business Quant data shows BBLGW's Assets at $5.8 million in Q4 2025, $6.4 million in Q3 2025, and $7.0 million in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 5.80 Mn
Sep 30, 2025 6.35 Mn
Jun 30, 2025 7.00 Mn
Mar 31, 2025 3.16 Mn
Dec 31, 2024 3.86 Mn
Sep 30, 2024 4.07 Mn
Jun 30, 2024 3.19 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 3.74 Mn
Sep 30, 2023 4.98 Mn
Jun 30, 2023 7.62 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 8.50 Mn
Sep 30, 2022 5.20 Mn
Jun 30, 2022 5.66 Mn
Mar 31, 2022 6.09 Mn
Dec 31, 2021 6.68 Mn
Sep 30, 2021 52,393.00
Jun 30, 2021 4,438.00
Mar 31, 2021 71,165.00